Presentation PCI Outcomes 2013 Perspectives on the Selection and Duration of Dual Antiplatelet Therapy Presenter: Dominick J. Angiolillo March 07, 2013 REGISTER for free or LOG IN to view this content CAD Pharma Presentation PCI Outcomes 2013 Up Next Presentation TCT 2015 Scotland Presents: How Did I Treat This Case? Presenter: Margaret B. McEntegart October 12, 2015 More slides + Presentation TCT 2015 ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes Presenter: Bernard R. Chevalier October 12, 2015 Presentation TCT 2015 Complications of CTO PCI: A Review of the Global Registries Presenter: Curtiss T. Stinis October 12, 2015 We Recommend
Presentation TCT 2015 Scotland Presents: How Did I Treat This Case? Presenter: Margaret B. McEntegart October 12, 2015
Presentation TCT 2015 ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes Presenter: Bernard R. Chevalier October 12, 2015
Presentation TCT 2015 Complications of CTO PCI: A Review of the Global Registries Presenter: Curtiss T. Stinis October 12, 2015